Nalaganje...
BiRd方案治疗复发难治多发性骨髓瘤的回顾性研究
OBJECTIVE: To evaluate efficacy of the BiRd regimen, a combination of clarithromycin, lenalidomide, and dexamethasone, in the treatment of patients with relapsed/refractory multiple myeloma (RRMM). METHODS: Patients with RRMM treated with BiRd between September 11, 2013 and August 1, 2016 at six cen...
Shranjeno v:
| izdano v: | Zhonghua Xue Ye Xue Za Zhi |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Editorial office of Chinese Journal of Hematology
2017
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7364962/ https://ncbi.nlm.nih.gov/pubmed/29166734 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3760/cma.j.issn.0253-2727.2017.10.003 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|